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Abstract
The aim of current study was to examine clonal structure and genetic profile of invasive
Staphylococcus aureus isolates recovered from infants and children treated at the Jagiello-
nian University Children’s Hospital of Krakow, Poland. The 107 invasive S. aureus isolates,
collected between February 2012 and August 2014, were analysed retrospectively. Antimi-
crobial susceptibility testing, spa typing and DNAmicroarray analysis were performed to
determine clonal distribution, diversity and gene content in regard to patients characteris-
tics. In total, 107 isolates were recovered from 88 patients with clinical symptoms of invasive
bacterial infection. The final set of 92 non-duplicate samples included 38 MRSA isolates.
Additionally, a set of 54 S. aureus isolates collected during epidemiological screening was
genotyped and analysed. There were 72 healthcare-associated (HCA) and 20 community-
onset (CO) infection events caused by 33 and 5 MRSA isolates, respectively. The majority
of isolates were affiliated with the major European clonal complexes CC5 (t003, spa-CC
002), CC45 (spa-CC 015), CC7 or CC15 (t084, t091, spa-CC 084). Two epidemic clones
(CC5-MRSA-II or CC45-MRSA-IV) dominated among MRSA isolates, while MSSA popula-
tion contained 15 different CCs. The epidemiological screening isolates belonged to similar
genetic lineages as those collected from invasive infection cases. The HCA infection
events, spa types t003, t2642 or CC5 were significantly associated with infections occurring
in neonates and children under 5 years of age. Moreover, carriage of several genetic mark-
ers, including erm(A), sea (N315), egc-cluster, chp was significantly higher in isolates
obtained from children in this age group. The spa types t091 and t008 were underrepre-
sented among patients aged 5 years or younger, whereas spa type t008, CC8 and presence
of splE was associated with infection in children aged 10 years or older. The HCA-MRSA
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strains were most frequently found in children under 5 years, although the majority of inva-
sive infections was associated with MSSA strains. Moreover, an association between age
group of children from the study population and a specific strain genotype (spa type, clonal
complex or genetic content) was observed among the patients.
Introduction
Staphylococcus aureus is one of major human pathogens, associated with wide spectrum of
localized or systemic infections, including bacteremia or sepsis. In younger patients, neonates
and children, the prolonged hospitalization, antibiotic exposure, invasive procedures and
devices have been indicated to increase risk of infection with multi-resistant pathogens [1].
According to the Polish Neonatology Surveillance Network report, between the years 2009-
2012, S. aureus was responsible for 6.5% of infections in newborns. Approximately 33% of
those events was caused by methicillin resistant S. aureus (MRSA) [2]. In United Kingdom, S.
aureus was reported as a common cause of late onset of neonatal sepsis, and was identified in
13% of bacterial isolates from blood cultures of neonates aged from 0 to 28 days [1]. Similarly,
in Sweden, S. aureus was the most common pathogen found in blood samples from children
undergoing infection, irrespectively of underlying risk factors [3]. Although, both MRSA and
methicillin susceptible (MSSA) S. aureus strains are responsible for only 1% of all-cause bac-
teremia and meningitis in infants, observed mortality rates are high and amount to 26% and
24%, respectively [1]. The severity and outcome of infection depend strongly on the virulence
repertoire of invasive strain and immune system status of the host. Especially, the immuno-
compromised patients have an increased risk of S. aureus colonization, potentially followed
by infection, further morbidity and unfavourable outcome. Risk of acquisition of multi-resis-
tant pathogens can be elevated by preterm birth, very low birth weight, frequent or long-term
admissions, need for antimicrobial therapy, presence of comorbidities or/and immune dys-
function [3–5]. Among children with malignancy, congenital heart disease or liver transplant
recipients, S. aureus accounts for up for 9–13%, 13% and 20% of blood stream infections,
respectively [4,6–8]. The effective prevention is greatly impeded, as S. aureus is ubiquitous in
the environment and its asymptomatic carriage is more a rule than an exception. Moreover,
treatment of S. aureus infections is challenging due to its multi-resistant profile and ability to
produce a wide range of virulence factors, including staphylococcal enterotoxins, proteases,
leukocidins, proteins associated with immune-evasion or adhesion [9,10]. Many epidemio-
logical investigations have been focused on S. aureus strains recovered from blood specimens
or invasive infections, but only a few have studied strains collected from paediatric patients
[1,11]. The aim of current study was to examine clonal structure of isolates recovered from
invasive infections in infants and children treated at the Jagiellonian University Children’s
Hospital of Krakow, Poland. Moreover, emergence and distribution of S. aureus genotypes
were analysed, and supplemented with results from typing of isolates from epidemiological
screenings. Utilization of spa typing and DNA microarrays (StaphyType, Alere Technologies)
allowed for molecular characterization of S. aureus, including resistance and virulence mark-
ers profiling. Moreover, the relationships between age and epidemiological classification of
infection event, resistance profile, corresponding strain spa type or clonal complex (CC),
were investigated.
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Materials and Methods
Hospital characteristics
The study was conducted at the Jagiellonian University Children’s Hospital (UCH): a 529-bed,
tertiary care referral clinic and academic institution located in Krakow metropolitan area, in
Malopolska region of South Poland. UCH is a highly specialized reference center for most
severely ill paediatric patients including children with neoplastic diseases, neonatal heart
defects, burns, congenital defects, neonates with low birth weight or undergoing bone marrow
transplants. Annually UCH holds app. 36 000 admissions and 150 000 outpatients from all
over Poland and abroad, with the majority originating fromMalopolska, Silesian or Subcarpa-
tian regions. Therefore, UCH provides medical and surgical care for children born in popula-
tion of approximately 10 mln people and 45 360 km2 area, comparable to Slovakia or other
medium-sized European country. Included 88 patients originated from over 50 cities of South
Poland and were treated in thirteen departments in UCH: Pathology and Neonatal Intensive
Care (IC) Unit (n = 22, mean age 0.1 year, approximately 40 days), Nutritional Therapy
(n = 11, mean age 2.7 years), Anaesthesiology and IC Unit (n = 11, mean age 5.2 years), Neuro-
surgery (n = 10, mean age 2.6 years), Rehabilitation (n = 7, mean age 7.0 years), Surgery (n = 8,
mean age 0.7 year, approximately 7 months), Haematology and Oncology (n = 7, mean age 8.7
years), Cardiac Surgery and Cardiac IC (n = 3, mean age 0.2 year, approximately 2 months),
Cardiology (n = 2, mean age 0.8 year, approximately 10 months), Gastroenterology (n = 2,
mean age 3.4 years), IC (n = 2, mean age 12.7 years), Rheumatology and Environmental Dis-
eases (n = 2, mean age 10.6 years), and Transplantology (n = 1, age 4.5 years). Moreover, a set
of epidemiological screening isolates was collected from none-invasive infection patients, med-
ical personnel, hospital spaces (e.g. nurse station, operating room) or equipment. The study
was approved by Jagiellonian University and UCH Committee, as this was a retrospective
study focused on bacteria characterization and did not require any patient involvement.
Definitions
An invasive infection was defined as localized or systemic inflammatory response to the pres-
ence of S. aureus at otherwise sterile anatomical sites as blood, cerebrospinal fluid (CSF) or
dialysis fluid (DF). Infection events were classified as community-onset (CO) when the positive
culture was obtained from patients within the first 48 h of admission. The healthcare-associ-
ated (HCA) infection has been defined when symptoms developed 48 h after admission or
within this period if the patient fulfilled any of the following criteria: i) patient have been hospi-
talized previously in UCH within the study period; ii) patient have been transferred to UCH
from other healthcare facility; iii) patient have been treated in Department of Nutritional Ther-
apy due to requirement of total parenteral nutrition and long-term presence of central venous
catheter. The term infant was applied to young children under 1 year of age. The neonate refers
to an infant in the first 1 month (30 days) of age. The mortality was the all-cause mortality
[12,13].
Bacterial isolates
From February 2012 to August 2014, 107 S. aureus isolates from invasive infection episodes
detected and treated in UCH were recovered for this study. All isolates were collected from
patients who developed clinical symptoms such as fever, leukocytosis, high level of procalcito-
nin or C-reactive protein on admission or during hospitalization. Clinical specimens, including
blood (83.2%), CSF (14.0%) or DF (2.8%) were collected. Additionally, epidemiological screen-
ing swabs of S. aureus isolates were collected in three UCH departments (Cardiac Surgery and
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Cardiac IC n = 18; Nutritional Therapy n = 25; Pathology and Neonatal IC, n = 11) between
September and November 2013. Overall 54 isolates were collected from 7 patients (mostly
nasal swabs, n = 7), 32 members of medical personnel (nasal swabs or/and hand smears on
agar substrate, n = 36) or environment (swabs of equipment, toys, hospital spaces as nurse sta-
tions or air probes, n = 11). Samples were inoculated into media optimized for detection of
common paediatric pathogens. The BACTEC Peds Plus/F is culture medium that accommo-
dates small-volume samples (3 ml of blood) and includes resins for antibiotic neutralization.
Incubation with continuous monitoring and automatic testing was performed in Bactec FX sys-
tem (Becton Dicknson, Franklin Lakes, NJ, USA). Positive samples were cultured on blood
agar plates containing 5% sheep blood (20–24 h at 37°C). The S. aureus identification was per-
formed by routine microbiology methods and VITEK1 2 automated system (bioMérieux,
Marcy l'Etoile, France). The isolates were further stored in tryptic soy broth with 10% glycerol
at -80°C before re-culturing for purpose of current study.
DNA extraction
For genomic DNA preparation, the S. aureus isolates were grown overnight (18–20 h at 37°C)
on blood agar plates. Several colonies (full inoculation loop) were homogenized with a Tissue-
Lyzer II (Qiagen, Hilden, Germany), and genomic DNA was extracted using DNeasy Blood
and Tissue Kit (Qiagen, Hilden, Germany) according to manufacturer’s instructions.
Susceptibility testing
Susceptibility testing was carried out according to EUCAST recommendations [14]. MRSA iso-
lates were identified using cefoxitin disks (30 μg) (Oxoid Ltd., Cambridge, UK), which was fur-
ther confirmed by the detection ofmecA gene in the DNAmicroarray analysis. The inducible
macrolide-lincosamide-streptogramin B (MLSB) resistance was detected by disk diffusion
method with use of clindamycin disks (2 μg) and erythromycin disks (15 μg) set 15–26 mm
apart on Mueller-Hinton agar inoculated with S. aureus bacterial suspension (turbidity
adjusted to 0.5 McFarland standard). The inducible phenotype causes a D-shaped inhibition
zone around the clindamycin disk, blunted from the side of erythromycin disk. In the case of
efflux mechanism of resistance, the entire zone of inhibition surrounding clindamycin disk is
round. Other antibiotics tested via disc-diffusion method included: gentamicin (10 μg), linezo-
lid (30 μg) or netilmicin (30 μg). Teicoplanin and vancomycin susceptibilities were determined
by using E-test strips (bioMérieux, Marcy l'Etoile, France) according to the manufacturer’s
instructions.
spa typing
The spa typing, based on amplification of the variable X region of protein A gene, was per-
formed as described previously [15]. The spa types were assigned using the Ridom StaphType
software version 1.4 (Ridom GmbH, Würzburg, Germany) and the Ridom SpaServer (http://
www.spaserver.ridom.de). The based upon repeat pattern (BURP) algorithm was used to
calculate spa clonal complexes (spa-CCs) with following parameters: no exclusion regarding
number of repeats; cost less or equal to 4; a cluster composed of 2 or more related spa types was
regarded as CC; a spa type that was not grouped into a CC was considered a singleton.
DNAmicroarray-based genotyping
The StaphyType system (StaphyType, Alere Technologies, Jena, Germany) is a microarray
assay for diagnostic testing and/or epidemiological investigations. Briefly, the StaphyType kit
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allows for simultaneous detection of 334 S. aureus target sequences, including approximately
170 distinct genes and their allelic variants. The DNA microarray procedures were carried out
according to the manufacturer's instructions. The assignment of strains to CCs or sequence
types (STs) was performed automatically by StaphyType software [16]. In order to visualize
strain relatedness, the obtained hybridization patterns were analysed using Splits Tree 4 soft-
ware (www.splitstree.org) on default setting. Results for every single gene were converted into a
code marked such: A = positive, T = negative, C = ambiguous, and used for construction of
unrooted phylogenetic network [17].
Statistical analysis
Differences of proportions in particular categorical data were assessed using Fisher’s exact test.
The p-values<0.05 were considered as statistically significant.
Results
Patients and isolates characteristics
The collection comprised 107 S. aureus isolates recovered from 88 paediatric patients with
symptoms of invasive infection and additionally 54 epidemiological screening isolates. Com-
plete isolate information is provided in S1 Table. One isolate per patient was collected in the
majority of invasive infection cases (73/88). Two isolates were obtained from each of thirteen
patients, and two patients were identified with four isolates each. As summarized in Table 1,
only first episode of S. aureus infection was considered for analysis in these 15 ‘multiple infec-
tion’ cases, with the exception of patients who experienced two separate episodes of infection
with genetically different strains i.e. characterized by different spa types and/or affiliated with
different CCs/SCCmec types. Therefore, the clonal structure and statistical analysis were based
on a set of 92 non-duplicate invasive S. aureus isolates obtained from 88 patients, as summa-
rized in detail in S2 Table.
The median age of patients at the time of testing was 0.8 year (range, 5 days to 17.7 year).
Almost half of the isolates (n = 42, 45.7%) was collected from infants under 6 months of age,
including 21 neonates (22,8%). Male patients prevailed in analysed population (60.2%).
Healthcare-associated infections dominated in children age under 5 years. Among the
92 non-duplicate S. aureus isolates, 72 invasive infection episodes were classified as HCA
(78.3%) and 20 episodes as CO (21.3%). Based on observed frequencies of infection events in
the current study, patients under 5 years were significantly predisposed for HCA infection,
while older children were associated with CO infection as presented in Table 2. The MRSA iso-
lates accounted for 45.8% and 25.0% of HCA (33/72) and CO events (5/20), respectively. Simi-
larly, considering associations observed for infection events, the HCA-MRSA isolates were
significantly more often recovered from neonates and children under 5 years, while CO-MSSA
in older patients (Table 2).
Mortality. During the study period, the 14 day all-cause mortality was 3.4% (3/88) and
overall mortality equalled 4.5% (4/88). No statistically significant association was found between
fatal outcome and characteristics of strains recovered from those four patients.
Antimicrobial susceptibility testing
Among all tested isolates thirty-eight (41.3%) were MRSA positive. As summarized in Table 2,
infants within first 6 months or 1 year after birth were significantly predisposed for infection
by MRSA strains. Moreover, MRSA strains were rarely isolated from children aged 5 years or
older. The MLSB resistance was detected in 34 (37.0%) isolates. The association between MLSB
Clonal Structure Characterization S. aureus Invasive Infections in Paediatric Patients South Poland
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spa-CC DNA microarray CC
PL274 AF 10.5
y
1st - NT blood t913 spa-CC 012 CC30-MSSA
PL304 11.1
y
2nd 233 G blood
PL322 AT 3.1 y 1st - NT blood t031 spa-CC 015 CC45-MSSA
PL209 3.5 y 2nd 146 NT blood t091 spa-CC 084 CC7-MSSA
PL291 AX 1.6 y 1st - N blood t056 spa-CC 056 (no
founder)
CC101-MSSA
PL296 1.7 y 2nd 36 N blood
PL303 AY 1.4 y 1st - R blood t091 spa-CC 084 CC7-MRSA-IV
PL312 1.6 y 2nd 93 R DF
PL347 2.7 y 3rd 386 (479 from 1st) R DF
PL349 2.7 y 4th 11 (490 from 1st) R DF t003 spa-CC 002 ST5/ST225-MRSA-II, Rhine-
Hesse EMRSA
PL271 BF 1 m 1st - CIC blood t015 spa-CC 015 CC45-MRSA-IV, Berlin
EMRSA
PL272 1 m 2nd 2 CIC blood
PL279 BL 28 d 1st - PN blood t003 spa-CC 002 ST5/ST225-MRSA-II, Rhine-
Hesse EMRSA
PL280 28 d 2nd 0 PN CSF
PL281 1 m 3rd 5 PN CSF
PL283 1 m 4th 3 (8 from 1st) PN blood
PL287 BR 6 d 1st - PN blood t283 singleton CC5-MRSA-IV, Paediatric
clone [sed/j/r+]
PL288 8 d 2nd 2 PN blood
PL297 BS 2 m 1st - NT blood t015 spa-CC 015 CC45-MRSA-IV, Berlin
EMRSA
PL205 1.1 y 2nd 313 NT blood t037 spa-CC 012 CC30-MSSA
PL236 CA 1.9 y 1st - NT blood t084 spa-CC 084 CC15-MSSA
PL348 2.0 y 2nd 39 NT blood
PL208 CG 1.2 y 1st - NT blood t124 singleton CC45-MSSA
PL357 1.8 y 2nd 226 NT blood
PL250 CN 28 d 1st - PN blood t091 spa-CC 084 CC7-MSSA
PL269 28 d 2nd 0 PN CSF
PL334 CO 4 m 1st - PN CSF t2642 spa-CC 2642 CC45-MRSA-IV, Berlin
EMRSA
PL336 5 m 2nd 30 PN blood
PL327 CQ 3 m 1st - S blood t127 singleton CC1-MSSA
PL339 7 m 2nd 100 G blood
PL335 CV 7 d 1st - PN blood t14391 singleton CC398-MSSA
PL238 28 d 2nd 21 PN blood t003 spa-CC 002 ST5/ST225-MRSA-II, Rhine-
Hesse EMRSA
PL355 CZ 4 m 1st - N blood t005 singleton CC22-MSSA
PL356 4 m 2nd 1 N CSF
The S. aureus isolates selected for statistical analysis are bolded.
aTo protect patients’ identity an alphabetic code has been assigned to each patient which had no correlation with patient’s names or initials.
y—year; m—month; d—day; NT—nutritional therapy, G—gastroenterology; N—neurosurgery; R—rehabilitation; CIC—cardiac surgery and cardiac
intensive care; PN—pathology and neonatal intensive care; S—surgery; CSF—cerebrospinal ﬂuid; DF—dialysis ﬂuid
doi:10.1371/journal.pone.0151937.t001
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Table 2. Identified statistically significant associations between age of patients and infection event classification/UCH departments/HAMRSA/CO
MSSA/ MRSA/MLSB/spa type/spa-CC/CC.
Groups Subgroups Age groups
<1 month <6 months <1 year <3 years <5 years >5 years >10 years
N = 21 N = 42 N = 49 N = 64 N = 70 N = 22 N = 14
HCAa n = 21 " n = 39 " n = 45 " n = 58 " n = 62 " n = 10 # n = 7 #
N = 72 p = 0.005 p = 0.002 p = 0.0009 p = 0.00004 p = 0.00008 p = 0.00008 p = 0.01
COb n = 0 " n = 3 " n = 4 " n = 6 " n = 8 " n = 12 " n = 7 "
N = 20 p = 0.005 p = 0.002 p = 0.0009 p = 0.00004 p = 0.00008 p = 0.00008 p = 0.01
Pathology and Neonatal IC n = 17 " n = 22 " n = 23 " n = 23 " n = 23 " n = 0 # n = 0 #
N = 23 p = 0.0001 p = 0.0001 p = 0.0001 p = 0.0001 p = 001 p = 001 p = 0.02
Nutritional Therapy n = 0 # n = 1 # n = 3 #
N = 13 p = 0.03 p = 0.003 p = 0.03
Rehabilitation n = 1 # n = 3 # n = 5 "
N = 8 p = 0.02 p = 0.02 p = 0.02
Haematology and Oncology n = 0 # n = 0 # n = 1 # n = 6 "
N = 7 p = 0.004 p = 0.0001 p = 0.0006 p = 0.0006
HCA MRSA n = 15 " n = 25 " n = 26 " n = 31 " n = 31 " n = 2
N = 33 p = 0.0002 p = 0.00002 p = 0.0004 p = 0.0001 p = 0.002 p = 0.002
CO MSSA n = 0 # n = 2 # n = 2 # n = 4 # n = 5 # n = 10 " n = 5 "
N = 15 p = 0.02 p = 0.009 p = 0.001 p = 0.0002 p = 0.0001 p = 0.0001 p = 0.048
MLSB n = 15 " n = 23 " n = 26 " n = 29 "
N = 34 p = 0.0005 p = 0.002 p = 0.001 p = 0.02
MRSA n = 15 " n = 26 " n = 28 " n = 33 " n = 34 # n = 4 #
N = 38 p = 0.002 p = 0.0003 p = 0.001 p = 0.003 p = 0.01 p = 0.01
MRSA and MLSB n = 12 " n = 20 " n = 21 " n = 23 " n = 23 " n = 2 #
N = 25 p = 0.001 p = 0.0001 p = 0.0003 p = 0.004 p = 0.03 p = 0.03
spa types t003 n = 10 " n = 12 " n = 13 " n = 14 " n = 14 " n = 0 # n = 3 "
N = 14 p = 0.00003 p = 0.001 p = 0.001 p = 0.004 p = 0.02 p = 0.02 p = 0.01
t008 n = 1 # n = 3 "
N = 4 p = 0.04 p = 0.04
t091 n = 1 #
N = 10 p = 0.02
t2642 n = 5 "
N = 5 p = 0.02
spa-CCs spa-CC 002 n = 10 " n = 14 " n = 17 " n = 18 " n = 19 " n = 0 #
N = 19 p = 0.001 p = 0.009 p = 0.0005 p = 0.01 p = 0.005 p = 0.005
spa-CC 008 n = 3 "
N = 5 p = 0.02
spa-CC 084 n = 4 #
N = 20 p = 0.01
CCs CC5 n = 12 " n = 17 " n = 20 " n = 22 " n = 23 " n = 0 # n = 0 #
N = 23 p = 0.0003 p = 0.003 p = 0.0002 p = 0.001 p = 0.001 p = 0.001 p = 0.02
CC8 n = 3 "
N = 6 p = 0.04
The " and # symbols indicate that given category is over and underrepresented in analysed age group, respectively.
HCA—health-care associated; CO—community onset; CC—clonal complex; IC—Intensive Care; MRSA—methicillin resistant S. aureus; MSSA—
methicillin susceptible S. aureus; MLSB−macrolide-lincosamide-streptogramin B (resistance)
aHCA group comprised of 33 MRSA and 39 MSSA isolates.
bCO group comprised of 5 MRSA and 15 MSSA isolates.
doi:10.1371/journal.pone.0151937.t002
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resistance and invasive infection was inversely proportional to the age of patients (Table 2).
Statistical significance was detected in children under 3 years, under 1 year, and was most sig-
nificant in neonates. The twenty-five isolates classified as both MRSA and MLSB, were mainly
recovered from children under 5 years of age, and mostly overrepresented among isolates caus-
ing infection in infants. As presented in S1 Table, all tested isolates were sensitive to linezolid,
gentamycin and vancomycin and only one was teicoplanin resistant (MIC 4.0 μg/ml).
spa typing
The analysis of 92 non-duplicate isolates yielded 37 spa types. Twelve types were shared by 2 or
more isolates (n = 67, 72.8%), while 25 types were represented by a single isolate (27.2%). One
new spa type was identified (t14391, n = 1) during this study. The most predominant spa types
were t003, t015 and t091 accounting for 14, 13 and 11 isolates, respectively. The BURP algo-
rithm (cost4) assigned isolates to 7 spa-CCs (n = 73, 79.3%) and 19 singletons. Three spa-
CCs dominated (spa-CC 084, n = 20; spa-CC 002, n = 19; spa-CC 015, n = 15) and accounted
for 58.7% of all analysed isolates as presented in Fig 1 and additionally in S2 Table.
spa types and spa-CCs were associated with age of patients. As summarized in Table 2,
spa type t003 comprised majority of S. aureus isolates in the age groups under 5 years of age
demonstrating statistically significant association with invasive infections in infants and young
children. Moreover, spa type t003 was not detected in any patient of 5 years or older. The spa
type t2642 was obtained only from infants under 6 months of age, while type t091 was signifi-
cantly underrepresented in this age group and isolated mainly from older paediatric patients.
The spa type t008 was also more common in older children, and its association with infection
increased slightly along with age (age groups of over 5 years and under 10 years). The statistical
analysis of spa-CCs yielded results corresponding to that obtained for particular spa types.
Thereby spa-CC 002 (composed of spa types t002, t003, t010, t088, t306) demonstrated signifi-
cant association with infection in all age groups under 5 years, with all included spa types col-
lected only from children between 5 days and 5 years of age. The spa-CC 084 (composed of spa
types t084, t091 t360, t3850) was underrepresented in infants under 6 months of age, while
spa-CC 008 (represented by spa types t008 and t1911) demonstrated association with infection
in children aged 10 years or older.
spa types were stable and non-time related replacement was observed. During the study
period 15 patients were sampled repeatedly and in majority of cases, the same spa type was
identified (Table 1). The difference in time between subsequent testing ranged from 1 to 490
days (approximately 16 months). From 4 patients, two different spa types were collected: i) spa
type t031 was replaced by type t091 (patient’s code AT); t091 by t003 (AY); iii) t015 by t037
(BS); iv) t14391 by t003 (CV). The interval between culture testing was 146 days, 11 days, 313
days and 21 days, respectively (Table 1). In any of those cases the two consecutive spa types
were related according to BURP clustering results.
DNAmicroarray typing
The DNA microarray-based assignment of 92 investigated isolates to CCs or STs is presented
in S2 Table. A total of 8 CCs were detected. The most predominant were CC45 (n = 24), CC5
(n = 23) and CC7 (n = 11), which together constituted majority (63.0%) of analysed collection.
The remaining five CCs were represented by less than 10 isolates each, which together included
34 isolates (37.0%). Affiliation to CCs and hybridization pattern similarity of all 107 isolates
from current study is presented as phylogenetic network in Fig 2. All identified CCs included
MSSA strains, which were highly diversified in comparison to methicillin resistant population.
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Fig 1. Population structure of 161 S. aureus isolates, including 107 invasive and 54 epidemiological screening isolates, collected in UCH (Krakow,
Poland) after BURP analysis with a cost of 4. Clusters of linked spa types correspond to spa clonal complexes (spa-CCs). The spa types that were defined
as founders of particular clusters are indicated in blue. In total, eight spa-CCs have been identified, with spa-CC 084, spa-CC 002, spa-CC 015 and spa-CC
037/021/012 accounting for 14 to 41 isolates, each. Eighteen spa types were regarded as singletons (n = 34).
doi:10.1371/journal.pone.0151937.g001
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The MRSA were detected only in major CCs and assigned to CC45-MRSA-IV (n = 20), ST5/
ST225-MRSA-II (n = 15), CC5-MRSA-IV (n = 2) or CC7-MRSA-IV (n = 1).
All isolates affiliated with CC5 were obtained from cases of invasive infection in children
aged 5 or younger (Table 2). The statistical analysis yielded results corresponding to obtained
for spa type t003 and spa-CC 002, which comprised majority of CC5 isolates. Therefore, CC5
was significantly associated with invasive infection children under 5 years of age. The isolates
affiliated with CC8 were statistically more common in children of 10 years of age and older,
similarly to results obtained for spa type t008 and spa-CC 008, also associated with infections
in this age group.
Hybridization profile stability. During the study period, 15 paediatric patients experi-
enced recurrent invasive infections. In the majority of cases, during subsequent isolation the
same strain was identified, characterized by the same spa type and gene content. Obtained
hybridization patterns were highly similar indicating stability of the analysed genes over time.
The 34 isolates sampled from 15 patients (>2 isolates each) are listed in Table 1 and presented
as phylogenetic network in Fig 2.
Gene content of isolates responsible for invasive infection is linked to clonal structure
and subsequently age related. The results of resistance and virulence markers profiling are
presented in S3 and S4 Tables.
MRSA strains are often multidrug-resistant and carriage of virulence markers is strongly
linked with affiliation to clonal groups (spa type, spa-CCs, CCs).The observed in this study
associations between genotype or/and methicillin resistance and patients age were reflected in
gene content. The resistance determinants,mecA, erm(A) and aadD, were overrepresented in
isolates from newborns, infants and children up to age of five, which corresponded to domi-
nant MRSA genotype (mainly t003, spa-CC 002, CC5) in these age groups. Similarly, in accor-
dance with clonal distribution, the agr group II (mainly t003, t283, t564 in CC5 and t084, spa-
CC 084, CC15) were significantly more commonly found in newborns, and in children under
age of five. As for the exotoxin genes, the egc-cluster encoding enterotoxins G, I, M, N, O and
U, was more prevalent in isolates obtained from patients under age of 5 years (mainly t003,
t002, t283, t564 in CC5; t015, t2642 in CC45), while enterotoxins D, J and R in infants (t003,
t283 in CC5), HCA infection events and female patients. Enterotoxin A, in allelic form of strain
N315 corresponding mostly to genotypes t003, spa-CC 002, CC5 or t091, spa-CC 084, CC7,
was detected significantly more often in neonates. The chemotaxis inhibiting protein (CHIPS)
was associated with invasive infection in infants and children under 3 years of age and was
found in isolates assigned to major genotypes detected among this age group (t015, CC45;
t003; CC5 or t084; CC15). All analysed isolates carried either capsular polysaccharide genes
associated with capsule type 5 (cap5) or type 8 (cap8). The cap 5 alleles were significantly more
common among infants, which is related with dominance of CC5 in this group. Serine protease
E (splE) was detected mostly in MSSA isolates assigned to 8 different spa types and correspond-
ing CCs. The gene was underrepresented in isolates obtained from children under 5 years of
age whereas in children at age of 10 years and older, and in samples from CO infection events
it was identified more frequently.
In overall, differences in carriage rates of several genetic markers were observed in MRSA
and MSSA isolates collected in UCH, as summarized in S4 Table. The erythromycin or tobra-
mycin resistance genes (erm(A), erm(C), aadD), enterotoxins D, J and R (sed, sej, ser), egc-clus-
ter encoding several enterotoxins, staphylokinase (sak), chemotaxis inhibiting protein (chp) or
fibrinogen-binding protein B (fnbB) were more prevalent in MRSA isolates. The toxic shock
syndrome toxin (tst-1) and accessory gene regulator III (agrIII) were detected solely in MSSA
isolates. Other genetic markers which were more commonly detected in this group included:
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haemolysin gamma C component (lukS), leucocidin D and E components (lukD, lukE), serine
proteases A, B or E (splA, splB, splE).
Emergence and distribution of S. aureus genotypes in UCH and its
departments
Samples have been collected over a period of study duration from February 2012 till August
2014. The use of spa and DNAmicroarray typing allowed to determine that the most common
Fig 2. A split network tree constructed from the hybridization results of all 107 invasive S. aureus isolates from paediatric patients and 54
epidemiological screening isolates collected in UCH (Krakow, Poland). SplitsTree analysis determined 6 major (CC5, CC45, CC7, CC30, CC15, CC8)
and 4 minor (CC1, CC10, CC22, CC395) clusters. There were 8 sporadic CCs represented by single/two isolates (CC9, CC25, CC101, CC97, CC779, CC12,
CC188, CC398). Identified MRSA lineages included CC45-MRSA-IV (Berlin EMRSA), ST5/ST225-MRSA-II (Rhine-Hesse EMRSA/New York-Japan Clone),
CC5-MRSA-IV (Paediatric clone [sed/j/r+]) and CC7-MRSA-IV. The spa types and/or spa-CCs are presented next to their respective CCs.
doi:10.1371/journal.pone.0151937.g002
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genotypes were present in UCH for a minimum of 1 year and a half, with the following geno-
types observed for the longest time periods: t015-CC45, t127-CC1 or t091-CC7. The distribu-
tion of isolates associated with particular genotypes is outlined in Fig 3.
The dominant t003-CC5 clone (n = 14), comprising mainly of MRSA identified as Rhine-
Hesse epidemic line (n = 13), emerged in March 2012 and have been further detected up to
November 2013 at Pathology and Neonatal IC department. Since all affected neonates were
initially treated at Obstetrics and Gynaecology departments of other regional (Malopolska)
hospitals, these infection events were classified as HCA Additionally, a single case of MSSA-
t003-CC5 isolate, also considered as HCA, was identified in Rehabilitation department in 2014.
The second most common genotype, t015-CC45 (n = 13), was found in 12 isolates and is
assigned to Berlin-EMRSA clone. One MSSA isolate was detected in Surgery department. The
t015-CC45-Berlin EMRSA clone was firstly encountered in February 2012 in CO infection
event at Haematology and Oncology department and was subsequently isolated in samples
from both CO and HCA infections occurring till June 2014 in in seven other UCH units. The
t091-CC7 clone (n = 12, including 11 MSSA) was initially identified in Nutritional Therapy
department and became a cause of CO or HCA infections in other seven different departments
between October 2013 and June 2014. The MSSA clone t084-CC15 (n = 6) also emerged in
Nutritional Therapy and was further identified in HCA or CO infection events in overall five
UCH departments between August 2013 and April 2014. Genotype t2642-CC45 (n = 5), also
assigned to Berlin-EMRSA epidemic line, was firstly detected in Surgery department in Octo-
ber 2012, later in 2013 in Pathology and Neonatal IC and in 2014 in Anaesthesiology and IC
department. All its cases were regarded as HCA. MSSA clone t008-CC8 (n = 4) was identified
in three HCA and one CO infection between June 2012 and August 2014, initially in Neurosur-
gery and later in two other UCH departments. All isolates affiliated to t127-CC1 (n = 4) were
MSSA and caused HCA invasive infections occurring firstly in Neurosurgery and later in Sur-
gery departments in period from August 2012 till July 2014. The details on remaining 30 geno-
types detected in UCH (n = 35) are provided in S2 Table and additionally in Fig 4 presenting
distribution of isolates collected from different UCH departments in respect to particular spa
type-microarray CCs.
Among the examined 13 UCH departments, Pathology and Neonatal IC Unit characterised
with significantly higher number of MRSA, HCA infection events and incidence of isolates
assigned to CC5, especially t003-CC5 genotype known as Rhine-Hesse epidemic line, when
compared to other UCH departments (p< 0.05). Interestingly, in the same department
t015-CC45 clone (mostly MRSA) was underrepresented and not detected among overall seven
genotypes identified (Fig 4). Due to the unit specificity, all tested isolates were collected from
neonates or infants. Consequently, patients under 1 year of age and younger were overrepre-
sented when compared with other departments (Table 2). As depicted in Fig 4, the highest
number of different S. aureus, mostly MSSA, was observed in the department of Nutritional
Therapy which also admitted significantly lower proportions of neonate or infant patients
(Table 2). Among the overall eight spa types identified in Anaesthesiology and IC department,
four were affiliated to CC45 (t015, t026, t116, t2642) which translates into the overrepresenta-
tion of that particular CC when compared to other isolation sites (p< 0.05). Significant major-
ity of infection events investigated in the department of Haematology and Oncology was
classified as CO (p< = 5), and occurred more often in children over 5 years of age as summa-
rized in Table 2. The genotype t091-CC7 was prevailed in this department (3 of 7 isolates total)
and was also detected in other six UCH departments. Children from Rehabilitation department
with invasive infections were in significant majority older than 5 years of age (Table 2), and
each of eight obtained infection isolates collected between 2012 and 2014 was associated with
different genotype (Fig 4). Similar genetic diversity was observed in Neurosurgery department,
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as among 9 genotypes identified only t015-CC45 was isolated more than once Fig 4). Although
t127-CC1 genotype initially observed in Neurosurgery unit, it was later detected and overrepre-
sented in Surgery department (p< 0.05).
Epidemiological screening results
Complete information and genotyping results for 54 S. aureus isolates obtained during epide-
miological screening are provided in S1 and S5 Tables, respectively. Overall, 27 spa types and
13 CCs (based on microarray analysis) were identified, with the highest prevalence of
t091-CC7 (n = 13), t037-CC30 (n = 5), t008-CC8 (n = 4) and t240-CC10 (n = 3) genotypes.
The single case of t003-CC5 isolate (PL245) was identified as MRSA carriage and with the use
of StaphyType software was assigned to Rhine-Hesse epidemic line. The screening process of
patients (n = 7) revealed the presence of six genotypes t002-CC5, t088-CC5, t091-CC7,
t230-CC45, t360-CC15 and t509-CC5. With exception of t230-CC45, the aforementioned
genotypes were also detected in isolates from invasive infection cases collected during the study
period. Three patients admitted to Nutritional Therapy department were tested both for
Fig 3. Distribution of 92 non-duplicate invasive S. aureus isolates assigned to particular spa type andmicroarray CCs genotypes collected over
study duration. The numbers in parentheses indicate the total number of isolates linked with each genotype. The three dominant genotypes (t003-CC5,
t015-CC45, t091-CC7) were present in UCH (Krakow, Poland) for almost entire study period, although no trend could have been observed. Remaining spa
type-CCs (n = 35) included 2 isolates each: t267-CC97, t564-CC5, t283-CC5, t360-CC15, t002-CC5; or 1 isolate each: t056-CC101, t209-CC9, t010-CC5,
t088-CC5, t005-CC22, t012-CC30, t340-CC45, t116-CC45, t1911-CC8, t122-CC30, t2229-CC8, t124-CC45, t037-CC30, t026-CC45, t306-CC5,
t3850-CC15, t349-CC25. MRSA (n = 38) included following major genotypes: t003-CC5 (n = 13), t015-CC45 (n = 12), t2642-CC45 (n = 5), and 6 minor:
t026-CC45, t091-CC7, t116-CC45, t283-CC5, t340-CC45, t564-CC5 with 1-2 representative isolates each.
doi:10.1371/journal.pone.0151937.g003
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Fig 4. Distribution of 92 invasive S. aureus isolates in respect to spa types andmicroarray CCs genotypes collected from all examined
departments of UCH (Krakow, Poland) during the study period between February 2012 and August 2014. The numbers in parentheses indicate the
total number of isolates associated with each genotype (spa type-microarray CC). MRSA (n = 38) included following genotypes: t003-CC5 (n = 13),
t015-CC45 (n = 12), t2642-CC45 (n = 5), t283-CC5 (n = 2), t564-CC5 (n = 2), t026-CC45 (n = 1), t091-CC7 (n = 1), t116-CC45 (n = 1) and t340-CC45 (n = 1).
doi:10.1371/journal.pone.0151937.g004
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invasive infection and S. aureus carriage (patients’ codes: AT, AW and CA; S1 Table). In May
2013, following the onset of invasive infection, patient AT was tested and positive for
t031-CC45 isolate (PL322). However, in October 2013 during a second onset of infection,
t091-CC7 genotype was isolated (PL209) which was also collected week later from nasal swab
during epidemiological screening (PL212). In case of patient AW, the isolate from invasive
infection occurring in August 2013 revealed the presence of t084-CC15 isolate (PL207). Later
in October 2013 the t002-CC5 genotype was identified in nasal swab (PL211). Similarly, patient
CA was initially a carrier of t002-CC5 genotype (PL213) as tested in October 2013, but the
invasive infection later in December 2013 (PL236) and January 2014 (PL348) was caused by
t084-CC15.
Among 36 isolates collected from medical personnel, t091-CC7 (n = 5), t037-CC30 (n = 4)
and t008-CC8 (n = 4) dominated, while 20 other spa types and their corresponding CCs were
identified in 23 remaining isolates (S5 Table). Fifteen, 11 and 10 isolates were obtained from
personnel working in Cardiac Surgery and Cardiac IC, Nutritional Therapy and Pathology and
Neonatal IC departments, respectively. In case of four personnel members encoded as ER, EW,
EX and FC, from which nasal swabs and hand smears/fingerprints on agar substrate were
retrieved, identical genotype was detected in both tested materials. As sample obtained in Sep-
tember 2013 suggests, one member of personnel was a carrier of t003-CC5-Rhine-Hesse
MRSA epidemic line (PL245) around that time. This epidemic clone emerged in UCH over
year earlier in March 2012. It was overrepresented and prevailed in Pathology and Neonatal IC
department during the study period. Other genotypes which were detected both in invasive
infection cases and as carriage by medical personnel were t091-CC7, t015-CC45, t008-CC8,
t037-CC30, t127-CC1, t360-CC15, t002-CC5, t005-CC5, t509-CC5, t012-CC30 and t209-CC9
(S1 Table).
The epidemiological screening of electronical or medical equipment, furniture, toys, door
handles or air yielded positive results for S. aureus presence (n = 11, mainly in Nutritional
Therapy department, n = 9). Majority of examined S. aureus-positive isolates was related to
t091-CC7 clone (n = 7), although four more genotypes were detected, t037-CC30, t124-CC45,
t240-CC10 or t653-CC5, with single representative isolate each. The t240-CC10 and t653-CC5
were identified to be carried by personnel or on equipment, but were not observed in invasive
infection cases (S1 Table).
The t091-CC7 was the only genotype detected in invasive infection cases (n = 14, including
3 MRSA) and in screening samples from patient (n = 1), medical personnel (n = 5) or UCH
equipment (n = 7, S1 Table).
Discussion
Staphylococcus aureus is one of the most common opportunistic pathogens in adult and paedi-
atric populations acquired in both community or hospital settings [3,7,18–20]. The current
study aimed to analyse S. aureus genotype, including virulence and resistance gene carriage,
with regard to age of children treated in UCH of Krakow, Poland. Approximately half of 107
analysed S. aureus isolates were collected from patients experiencing invasive infection at 1
year of age or younger, including neonates who developed symptoms between 5th and 28th
day after birth. The total of 88 paediatric patients originating from vast geographic region (45
300 km2) were admitted and arrived directly from home or were transferred to UCH from
other healthcare facilities. Due to highly specialized profiles of UCH clinics, the patients were
exposed to wide range of multi resistant pathogens. From the majority of cases one isolate was
collected, whereas 15 patients were repeatedly tested and positive to be infected (or re-infected)
with the same strain or various strains. Additionally, 54 epidemiological screening S. aureus
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isolates were retrieved and analysed to determine and track genotypes among non-invasive
infection patients, medical personnel, equipment and hospital spaces.
Majority of infection events which yielded the samples for this analysis were assessed as
HCA and occurred in population of infants and children not older than 5 years. These findings
correspond to previous reports from other countries. In Spain, in children with bloodstream
infections HCA S. aureus accounted for 77.2% episodes [21]. Further sources provide statistics
of similar magnitude. The Canadian report states that all S. aureus-related infections in neo-
nates were of HCA type [6]. In UK approximately two thirds of MSSA bacteraemia were
acquired in healthcare setting [22]. Also in this study, the presence of MRSA isolates of HCA
origin was detected most frequently in population of children aged 5 years or less. On the other
hand, the MSSA strains of CO origin were significantly more common among patients aged 5
years—10 years and older. However, in contrast to European and worldwide data, in present
set of samples only five have been obtained from infection episodes related to MRSA of CO ori-
gin [23–26].
Considering the risk of death due to S. aureus infection, recently an association has been
found between methicillin resistance and higher mortality rate in neonates and children diag-
nosed with S. aureus bacteraemia [27]. In the current study four fatal cases have been reported
and three of them were tested positive for MRSA in blood samples. The observed all-cause
mortality and 14 day all-cause mortality were comparable with previously reported in children,
but much lower than estimated for general population [6,12]. Study design and methodological
restraints did not allow to assess the impact of infection on health outcomes in patients.
In 15 patients, blood samples were collected several times at different time points. Eleven
patients were identified to be infected with strains of the same spa type and highly stable DNA
microarray profiles, as observed differences were of allelic or single locus nature. The remain-
ing four children had the same spa type detected in the first episode/s, but a different type in
the last analysed sample. The similar observation has been previously reported and postulated
as a tendency of patients to experience recurrent infections of initial infecting strain [22]. As
no clinical data were available, we could not determine whether the multiple testing was per-
formed as a part of therapy/monitoring or due to the episodes of re-infection.
The age-dependent incidence of S. aureus infection is widely documented. In two recent
studies, one multinational and one based on Danish medical database, the rates of bloodstream
infection are high in children under 1 year of age, drop significantly in older age groups, and
rise to equal and higher levels above age of sixty [28,29]. In a population based study from Can-
ada, the risk of developing S. aureus bacteraemia was highest in neonatal period and fell signifi-
cantly after 1 month of age and later childhood [6]. Yet, the association between S. aureus
genotype and age of the patient have been investigated only to a small extent. For instance, the
particular spa types have been associated with age of carriers in general population, moreover
CC5 and CC45 were reported to exhibit age preferences for carriage or infection in adults
[30,31].
In this study, in line with other European reports on genotyping, the types t003, t015, t091,
t084, t2642, t008, t127 and CCs: CC45, CC5 and CC7 dominated among the overall 51 spa
types and 18 CCs identified among all 161 tested isolates [12,21,31–34]. Some of the observed
major or minor genotypes exhibited age-related pattern of infection among patients treated in
UCH. The spa type t003, as well as spa-CC 002 and CC5 were strongly associated with invasive
infections in infants and young children. Additionally, these genotypes were the most common
among MRSA infections of HCA origin to be found in patients aged 5 years or less. Recently,
the t015-SCCmec type IV strains were identified as the most common cause of MRSA infec-
tions in Polish newborns [2]. However, in the current study no age relatedness was observed
for t015 (spa-CC 015, CC45), which was the second major MRSA genotype in UCH. In general,
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the predominance of spa types t003 and t015 among MRSA and HCA isolates is well docu-
mented. Both types are reported to be second in prevalence among MRSA spa types in Poland
and to frequently cause HCA-MRSA infections in Europe [12,30,35–37]. The t2642 (singleton,
CC45) was overrepresented in children under 5 years of age and not identified in older
patients. This spa type was not reported previously to infect children, but its presence was
found in Europe and detected in both MRSA and MSSA isolates as confirmed in the Ridom
spa server (http://spa.ridom.de/spa-t2642.shtml). The spa type t091 was underrepresented in
infants under 6 months of age and isolated mostly from older infants or children treated in
UCH. Similarly, the spa type t008 along with spa-CC 008 and CC8 were most commonly
obtained from patients above age of 5 or 10 years. Observed frequencies of t091 (CC7) and
t008 (CC8) are in accordance with previous reports, as this genotype is the most common
MSSA clone in Europe [37]. The spa type t008 was previously reported as one of the most com-
mon in paediatric MRSA-related infections in USA, although in the current study it was associ-
ated with MSSA infections [38].
Numerous attempts have been made to assess the virulence gene carriage in S. aureus bacte-
ria, CCs or even particular epidemic lines. According to findings of molecular genetics, the
host specificity of particular S. aureus lineages is reflected in strain genetic profile, through
presence or absence of allelic variations or insertions. Consequently, the observed gene fre-
quencies are complementary to genotyping data, resulting from number and proportions of
particular genotypes within analysed subgroups. In the current study, carriage of several
genetic markers was significantly higher among particular age groups, including egc-cluster,
sej/sed/ser, chp or splE. The results of recent murine model experiments, suggest that egc-cluster
(seg, seln, selu, sei, selm, selo), located on vSaβ genomic island, only marginally contributes to
virulence but might be involved in colonization of mucosal surfaces [39]. In the current study
egc-cluster was overrepresented among MRSA isolates (CC5, CC45), and similarly to CC5
genotype highly prevalent in children under 5 years of age. In Ireland, the high frequencies of
this MGE have been reported for MRSA strains [40]. However, the cluster was also detected in
several isolates lackingmecA gene, affiliated mostly to CC30, CC5, CC45 or other minor CCs,
corresponding to previous reports for MSSA infection [31,41,42].
In UCH isolates, the plasmid encoded enterotoxins D, J and R (sed+sej+ser) were overrepre-
sented in categories of MRSA isolates, children under 5 years old or female patients. Generally,
the enterotoxins D, J and R are common in clinical S. aureus isolates [36,43,44]. The sed+sej
+ser genes were detected in isolates of CC5 (both MRSA and MSSA) and CC8 (MSSA), and
most likely carriage within CC5 resulted in observed high frequencies in the analysed sub-
groups. The sed gene was earlier reported to be significantly more frequent among invasive
MRSA isolates [45,46]. Although the presence of enterotoxins in paediatric isolates from
bloodstream infections was previously reported in China, the dependency on age or sex was
not analysed, and current findings will require further investigation [11].
S. aureus bacteria produce factors responsible for evasion and modulation of the innate host
immune response [47,48]. The immune-evasion cluster (IEC) genes sak, chp and scn, encoding
staphylokinase, SCIN and CHIPS, respectively, are transmitted together by several staphylo-
coccal bacteriophages, integrating within hlb gene [47,49,50]. Although UCH isolates carrying
chp and sak, were nearly equally divided between MRSA and MSSA subgroups, both genes
were overrepresented among MRSA (CC5 and CC45). Similarly, high frequencies of IEC genes
were also observed among MRSA isolates in Ireland [40], although in Romania when charac-
teristics of MRSA and MSSA isolates were compared no differences were observed [51]. The
CHIPS was recently connected with nasal colonization of young children, which might par-
tially explain identified here age factor, as the gene was present in both MRSA and MSSA iso-
lates [47,52].
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The splE encoding serine protease E is frequently reported to be present in clinical S. aureus
strains and in this study was the only gene overrepresented in isolates collected from older chil-
dren [33,51,53]. This observation corresponds to higher rates of MSSA infection among UCH
patients over 5 or 10 years, as the splE was carried by several MSSA-CCs, mainly CC7, CC15,
CC8 or CC30. The age-related patterns of this determinant have not been reported previously.
The comparison between carriage and invasive isolates in Sweden showed no statistical differ-
ences [33].
Beside determinants discussed earlier, also some other resistance or virulence markers
were unevenly distributed between MRSA and MSSA isolates. In accordance with worldwide
reports, the MRSA isolates were characterized by significantly higher rates of genes mediating
resistance to MLS-antibiotics (erm(A)/(C)) or tobramycin/aminoglycosides (aadD) when
compared to MSSA-related values [40,44,54–56]. In the current study, the agr type III was
overrepresented among MSSA isolates, affiliated with CC1 or CC30, which corresponds to
results from other population based studies [16,56]. The observed rate of TSST-1 (tst-1),
associated with staphylococcal toxic shock syndrome, was much lower than reported in Nor-
way, Germany, Spain or other European countries [9,31,35,57,58]. The carriage rates of tst-1
were significantly higher in MSSA isolates. The lack of TSST-1 in MRSA subgroup might
have resulted from SaPI-mediated transmission of the gene [50,59,60]. Additionally, the dis-
tribution of TSST-1 was reported to follow CCs affiliation, and, indeed, the tst-1 gene was
detected mainly in CC30 [16,61,62]. Similarly, the serine proteases A and B (SplA, SplB) were
significantly more common in MSSA isolates. This observation corresponds to previous
reports, as those markers are often detected in clinical isolates in countries with low incidence
of MRSA [32,33,51,56]. Serine protease A and B are especially common in invasive S. aureus
infections or atopic dermatitis [33,63]. In the current study the lukS gene encoding γ-haemo-
lysin C component was overrepresented in MSSA isolates, while in a recent report from
Ukraine no differences were observed between MRSA and MSSA [64]. Similarly, although
the leukocidin components D and E are reported to be prevalent in MRSA clones, in the ana-
lysed collection lukE/D genes were more frequent in MSSA isolates [16,51,65] Those discrep-
ancies might have resulted from differences in S. aureus clonal distribution in Europe, and
lukS/E/D gene association with MSSA infection requires further verification. Fibrinogen-
binding protein, encoded by fib gene, was found significantly more often in MSSA isolates,
which corresponds to high rates of this gene reported in Sweden [56,58]. However, in a recent
study comparing MSCRAMMs carriage rates in paediatric isolates, no differences in fib gene
frequencies were observed in MRSA and MSSA groups [66]. Fibronectin-binding protein B
(fnbB) was present in all analysed MRSA isolates and consequently overrepresented in this
group, even with 85% rate in MSSA isolates. In general, the fnbB is usually present in CC5,
which in the current study was one of two major clones responsible for MRSA infection
among UCH patients [16].
Based on analysis results of S. aureus isolates retrieved from invasive infection cases and
during epidemiological screening, the major identified clones have been present in UCH since
year 2012, and circulating between patients, medical personnel, hospital spaces or equipment.
With few exceptions, identical genotypes have been detected in samples from invasive infection
episodes and screening, with t091-CC7 being most ubiquitous. Four distinct MRSA lineages
were found, with t003-CC5 clone (ST5/ST225-MRSA-II) known as ‘Rhine-Hesse EMRSA’
being predominant among invasive infection isolates from neonates or infants. Previously,
Rhine-Hesse isolates were classified as HCA and reported in Germany and Austria since year
1995 [16,67]. The most prevalent MRSA clone in UCH, CC45-MRSA-IV (Berlin EMRSA), was
firstly observed in Berlin hospitals in 1993 and later spread within healthcare institutions all
over Germany, the Netherlands and other European countries [68–71]. Similarly, widely
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reported lineage CC5-MRSA-IV (Paediatric clone [sed/j/r+]) most likely originated in Portu-
gal, being firstly described in paediatric hospital in 1999 [68,72,73]. Detection of above MRSA
epidemic lineages in South Poland paediatric hospital further affirms existence of international
transmission of HCA-associated clones described previously in European structured surveys
[12,37]. Among the examined departments, the Pathology and Neonatal IC Unit showed to
have significantly higher rates of HCA-MRSA. This highly specialised department of UCH is
dedicated for diagnosis and treatment of preterm infants, children with congenital defects,
inborn conditions, requiring mechanical ventilation and/or with symptoms of bacteraemia/
sepsis. Among paediatric patients tested and positive for S. aureus invasive infection treated in
this department, 16 were admitted from other hospitals in Malopolska (mostly from maternity
or neonatal units) and were source of 17 isolates as summarised in S1 Table. Five children were
admitted directly from home and in case patients BC (PL292) and BV (PL298) the admissions
were classified as emergency. Patient BJ was initially admitted to Cardiac Surgery and Cardiac
IC department but was later transferred to Pathology and Neonatal IC within UCH, where he
was tested and positive for S. aureus invasive infection (PL277, S1 Table). The emergence and
predominance of t003-CC5 genotype (including Rhine-Hesse epidemic line) in above UCH
unit, might be associated with significantly younger age of admitted patients and IC profile of
this department. It has been previously reported that invasive MRSA infections mostly occur
in children younger than 1 year of age, and presence of comorbidities, invasive devices, expo-
sure to broad-spectrum antibiotic or parenteral nutrition increase risk of infection [1,74–76].
The t003-CC5 (Rhine-Hesse epidemic line) was also the only MRSA clone detected in nasal
swab sample obtained from one member of medical personnel. Subsequently, the observed
MRSA carriage rate among UCH personnel (3.1%) was below worldwide estimate and results
reported in other studies [77–79]. Overall, genotypes identified during epidemiological screen-
ing belonged to similar genetic lineages as those collected from patients with invasive S. aureus
infection. The existence of an active transmission between patients, personnel and by contact
with medical/other equipment is highly suggestive, although its direction might not be only
towards the patients, but also vice versa. As reported recently, based on Whole-Genome
Sequencing (WGS) data gathered during MRSA outbreak, tracing evolutional changes in S.
aureus genomes suggests existence of much more complicated transmission patterns than
anticipated before introduction of WGS technology [80].
In, conclusion, invasive S. aureus infections, including bacteraemia or sepsis, are one of the
most fatal bacterial diseases worldwide. Both in immunocompromised or previously healthy
children, S. aureus is found to be a cause of approximately 10% of bloodstream or invasive
infections [3,20,81]. In the current study, high diversity of MSSA strains was observed, whereas
MRSA infection was of clonal nature, with few dominant lineages. The spa types predominant
in UCH of Krakow, Poland were similar to those reported in other European studies. The iso-
lates retrieved during epidemiological screening were mostly MSSA and belonged to similar
genetic lineages as those collected from patients with invasive infection. The association
between S. aureus genotype and age of patients was identified and shown in the population of
children under 5 years of age. The observed in UCH associations between genotype (spa types,
CC, genetic profile) and patients characteristics, might reflect microorganism and host match-
ing, where gene content of both pathogen and patient interact during colonization and patho-
genesis. However, the observed strain diversity indicate that host factors might be at least as
important as bacterial genetic profile during pathogenesis process explaining high incidence of
S. aureus invasive infections in children and adults. Our results ought to be further investigated
in the multiple-center settings in paediatric population to address the high incidence and bur-
den of S. aureus infections in infants and children.
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Supporting Information
S1 Table. Full information on 107 invasive infection and 54 epidemiological screening S.
aureus isolates collected in UCH (Krakow, Poland). Isolates included in statistical and epide-
miological analysis are highlighted in grey. Isolates collected during epidemiological screening
are highlighted in orange. To protect patients and medical personnel identity an alphabetic
code has been assigned to each, regardless of their names or initials. The presented data are
arranged chronologically. CSF- cerebrospinal fluid; DF—dialysis fluid; CC—clonal complex;
CO—community-onset; HCA—healthcare-associated; S—susceptible; R—resistant; MRSA—
methicillin resistant S. aureus; MSSA—methicillin susceptible S. aureus; MLSB—macrolide-lin-
cosamide-streptogramin B (resistance); N/A—not applicable; nd—no data.
(XLSX)
S2 Table. Classification and molecular typing data on 92 non-duplicate invasive S. aureus
isolates obtained from 88 paediatric patients treated in UCH (Krakow, Poland). CC—clonal
complex; CO—community-onset; HCA—healthcare-associated; MRSA—methicillin resistant
S. aureus; MSSA—methicillin susceptible S. aureus; MLSB—macrolide-lincosamide-streptogra-
min B (resistance).
(XLSX)
S3 Table. Identified statistically significant associations between age of paediatric patients
and carriage of gene markers among invasive S. aureus isolates collected in UCH (Krakow,
Poland). The grey background indicates that given category is overrepresented in analysed age
group.
(XLSX)
S4 Table. Identified statistically significant associations between HCA/CO infection event/
gender/methicillin resistance and carriage of gene markers among invasiveS. aureus iso-
lates collected in UCH (Krakow, Poland). The grey background indicates that given category
is overrepresented in analysed age group. CO—community-onset; HCA—healthcare-associ-
ated; M—male; F—female; MRSA—methicillin resistant S. aureus; MSSA—methicillin suscep-
tible S. aureus.
(XLSX)
S5 Table. Classification and molecular typing data on 54 S. aureus isolates collected during
epidemiological screening in UCH between September and October 2013 (Krakow,
Poland). Isolates collected during epidemiological screening are highlighted in orange. To pro-
tect patients and medical personnel identity an alphabetic code has been assigned to each,
regardless of their names or initials. The presented data are arranged chronologically. CC—
clonal complex; CO—community-onset; HCA—healthcare-associated; S—susceptible; R—
resistant MRSA—methicillin resistant S. aureus; MSSA—methicillin susceptible S. aureus;




Conceived and designed the experiments: AJS JM AWF. Performed the experiments: WMI VA
MK-S AB. Analyzed the data: WMI AJS VA AB JM. Contributed reagents/materials/analysis
tools: AWF AJS JM AS JK IS-S BW. Wrote the paper: WMI AJS JM ABMK-S AWF. Collected
and provided strain information: AS JK IS-S BW.
Clonal Structure Characterization S. aureus Invasive Infections in Paediatric Patients South Poland
PLOS ONE | DOI:10.1371/journal.pone.0151937 March 18, 2016 20 / 25
References
1. Shane AL, Stoll BJ. Neonatal sepsis: progress towards improved outcomes. J Infect. 2014; 68 Suppl 1:
S24–32. doi: 10.1016/j.jinf.2013.09.011 PMID: 24140138
2. Romaniszyn D, Różańska A, Wójkowska-Mach J, Chmielarczyk A, Pobiega M, Adamski P, et al. Epide-
miology, antibiotic consumption and molecular characterisation of Staphylococcus aureus infections—
data from the Polish Neonatology Surveillance Network, 2009–2012. BMC Infect Dis. 2015; 15: 169.
doi: 10.1186/s12879-015-0890-3 PMID: 25888217
3. Luthander J, Bennet R, Giske CG, Nilsson A, Eriksson M. Age and risk factors influence the microbial
aetiology of bloodstream infection in children. Acta Paediatr Oslo Nor 1992. 2013; 102: 182–186. doi:
10.1111/apa.12077
4. McNeil JC. Staphylococcus aureus—antimicrobial resistance and the immunocompromised child.
Infect Drug Resist. 2014; 7: 117–127. doi: 10.2147/IDR.S39639 PMID: 24855381
5. Wójkowska-Mach J, Gulczyńska E, Nowiczewski M, Borszewska-Kornacka M, Domańska J, Merritt
TA, et al. Late-onset bloodstream infections of Very-Low-Birth-Weight infants: data from the Polish
Neonatology Surveillance Network in 2009–2011. BMC Infect Dis. 2014; 14: 339. doi: 10.1186/1471-
2334-14-339 PMID: 24939563
6. Vanderkooi OG, Gregson DB, Kellner JD, Laupland KB. Staphylococcus aureus bloodstream infections
in children: A population-based assessment. Paediatr Child Health. 2011; 16: 276–280. PMID:
22547946
7. Vergnano S, Menson E, Smith Z, Kennea N, Embleton N, Clarke P, et al. Characteristics of Invasive
Staphylococcus aureus in United Kingdom Neonatal Units. Pediatr Infect Dis J. 2011; 30: 850–854. doi:
10.1097/INF.0b013e318224546d PMID: 21654546
8. Ascher SB, Smith PB, Clark RH, Cohen-Wolkowiez M, Li JS, Watt K, et al. Sepsis in young infants with
congenital heart disease. Early HumDev. 2012; 88 Suppl 2: S92–97. doi: 10.1016/S0378-3782(12)
70025-7 PMID: 22633525
9. Becker K, Friedrich AW, Lubritz G, Weilert M, Peters G, Von Eiff C. Prevalence of genes encoding pyro-
genic toxin superantigens and exfoliative toxins among strains of Staphylococcus aureus isolated from
blood and nasal specimens. J Clin Microbiol. 2003; 41: 1434–1439. PMID: 12682126
10. Calderwood MS, Desjardins CA, Sakoulas G, Nicol R, Dubois A, Delaney ML, et al. Staphylococcal
enterotoxin P predicts bacteremia in hospitalized patients colonized with methicillin-resistant Staphylo-
coccus aureus. J Infect Dis. 2014; 209: 571–577. doi: 10.1093/infdis/jit501 PMID: 24041793
11. Li T, Yu X, Xie J, Xu Y, Shang Y, Liu Y, et al. Carriage of virulence factors and molecular characteristics
of Staphylococcus aureus isolates associated with bloodstream, and skin and soft tissue infections in
children. Epidemiol Infect. 2013; 141: 2158–2162. doi: 10.1017/S0950268812002919 PMID:
23217217
12. Grundmann H, Aanensen DM, van denWijngaard CC, Spratt BG, Harmsen D, Friedrich AW, et al. Geo-
graphic distribution of Staphylococcus aureus causing invasive infections in Europe: a molecular-epi-
demiological analysis. PLoS Med. 2010; 7: e1000215. doi: 10.1371/journal.pmed.1000215 PMID:
20084094
13. Rello J, Kollef MH, Díaz E, Rodríguez A. Infectious Diseases in Critical Care. Springer Science & Busi-
ness Media; 2010.
14. Leclercq R, Cantón R, Brown DFJ, Giske CG, Heisig P, MacGowan AP, et al. EUCAST expert rules in
antimicrobial susceptibility testing. Clin Microbiol Infect. 2013; 19: 141–160. doi: 10.1111/j.1469-0691.
2011.03703.x PMID: 22117544
15. Aires-de-Sousa M, Boye K, de Lencastre H, Deplano A, Enright MC, Etienne J, et al. High Interlabora-
tory Reproducibility of DNA Sequence-Based Typing of Bacteria in a Multicenter Study. J Clin Microbiol.
2006; 44: 619–621. doi: 10.1128/JCM.44.2.619-621.2006 PMID: 16455927
16. Monecke S, Slickers P, Ehricht R. Assignment of Staphylococcus aureus isolates to clonal complexes
based on microarray analysis and pattern recognition. FEMS Immunol Med Microbiol. 2008; 53: 237–
251. doi: 10.1111/j.1574-695X.2008.00426.x PMID: 18507678
17. Huson DH, Bryant D. Application of phylogenetic networks in evolutionary studies. Mol Biol Evol. 2006;
23: 254–267. doi: 10.1093/molbev/msj030 PMID: 16221896
18. Anantha RV, Jegatheswaran J, Pepe DL, Priestap F, Delport J, Haeryfar SMM, et al. Risk factors for
mortality among patients with Staphylococcus aureus bacteremia: a single-centre retrospective cohort
study. CMAJ Open. 2014; 2: E352–359. doi: 10.9778/cmajo.20140018 PMID: 25553328
19. Bonnal C, Birgand G, Lolom I, Diamantis S, Dumortier C, L’Heriteau F, et al. Staphylococcus aureus
healthcare associated bacteraemia: An indicator of catheter related infections. Médecine Mal Infect.
2015; 45: 84–88. doi: 10.1016/j.medmal.2015.01.002
Clonal Structure Characterization S. aureus Invasive Infections in Paediatric Patients South Poland
PLOS ONE | DOI:10.1371/journal.pone.0151937 March 18, 2016 21 / 25
20. Hamer DH, Darmstadt GL, Carlin JB, Zaidi AKM, Yeboah-Antwi K, Saha SK, et al. Etiology of bacter-
emia in young infants in six countries. Pediatr Infect Dis J. 2015; 34: e1–8. doi: 10.1097/INF.
0000000000000549 PMID: 25389919
21. Barrado L, Brañas P, Rojo P, Gómez-González C, Barrios M, Orellana MA, et al. Molecular epidemiol-
ogy of Staphylococcus aureus bacteremia in children, Spain: low risk of methicillin resistance. J Infect.
2014; 68: 195–198. doi: 10.1016/j.jinf.2013.10.001 PMID: 24125904
22. Satta G, Ling CL, Cunningham ES, McHugh TD, Hopkins S. Utility and limitations of Spa-typing in
understanding the epidemiology of Staphylococcus aureus bacteraemia isolates in a single University
Hospital. BMC Res Notes. 2013; 6: 398. doi: 10.1186/1756-0500-6-398 PMID: 24088194
23. Britton PN, Andresen DN. Paediatric community-associated Staphylococcus aureus: a retrospective
cohort study. J Paediatr Child Health. 2013; 49: 754–759. doi: 10.1111/jpc.12255 PMID: 23721234
24. Gomes RT, Lyra TG, Alves NN, Caldas RM, Barberino M-G, Nascimento-Carvalho CM. Methicillin-
resistant and methicillin-susceptible community-acquired Staphylococcus aureus infection among chil-
dren. Braz J Infect Dis Off Publ Braz Soc Infect Dis. 2013; 17: 573–578. doi: 10.1016/j.bjid.2013.02.010
25. Qiao Y, Ning X, Chen Q, Zhao R, SongW, Zheng Y, et al. Clinical and molecular characteristics of inva-
sive community-acquired Staphylococcus aureus infections in Chinese children. BMC Infect Dis. 2014;
14: 582. doi: 10.1186/s12879-014-0582-4 PMID: 25377600
26. Li S, Ning X, SongW, Dong F, Zheng Y, Chen Q, et al. Clinical and molecular characteristics of commu-
nity-acquired methicillin-resistant Staphylococcus aureus infections in Chinese neonates. APMIS Acta
Pathol Microbiol Immunol Scand. 2015; 123: 28–36. doi: 10.1111/apm.12304
27. Park DA, Lee SM, Peck KR, Joo E-J, Oh EG. Impact of Methicillin-Resistance on Mortality in Children
and Neonates with Staphylococcus aureus Bacteremia: A Meta-analysis. Infect Chemother. 2013; 45:
202–210. doi: 10.3947/ic.2013.45.2.202 PMID: 24265968
28. Laupland KB, Lyytikäinen O, Søgaard M, Kennedy KJ, Knudsen JD, Ostergaard C, et al. The changing
epidemiology of Staphylococcus aureus bloodstream infection: a multinational population-based sur-
veillance study. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2013; 19: 465–471. doi:
10.1111/j.1469-0691.2012.03903.x
29. Gradel KO, Schønheyder HC, Arpi M, Knudsen JD, Ostergaard C, Søgaard M. The Danish Collabora-
tive Bacteraemia Network (DACOBAN) database. Clin Epidemiol. 2014; 6: 301–308. doi: 10.2147/
CLEP.S66998 PMID: 25258557
30. Sangvik M, Olsen RS, Olsen K, Simonsen GS, Furberg A-S, Sollid JUE. Age- and gender-associated
Staphylococcus aureus spa types found among nasal carriers in a general population: the Tromso Staph
and Skin Study. J Clin Microbiol. 2011; 49: 4213–4218. doi: 10.1128/JCM.05290-11 PMID: 21998436
31. Blomfeldt A, Aamot HV, Eskesen AN, Müller F, Monecke S. Molecular characterization of methicillin-
sensitive Staphylococcus aureus isolates from bacteremic patients in a Norwegian University Hospital.
J Clin Microbiol. 2013; 51: 345–347. doi: 10.1128/JCM.02571-12 PMID: 23135934
32. Luxner J, Zarfel G, Johler S, Feierl G, Leitner E, Hoenigl M, et al. Genetic characterization of Staphylo-
coccus aureus isolates causing bloodstream infections in Austria. Diagn Microbiol Infect Dis. 2014; 78:
153–156. doi: 10.1016/j.diagmicrobio.2013.10.010 PMID: 24321355
33. Rasmussen G, Monecke S, Ehricht R, Söderquist B. Prevalence of clonal complexes and virulence
genes among commensal and invasive Staphylococcus aureus isolates in Sweden. PloS One. 2013; 8:
e77477. doi: 10.1371/journal.pone.0077477 PMID: 24130888
34. Wiśniewska K, Szewczyk A, Piechowicz L, Bronk M, Samet A, Swieć K. The use of spa and phage typ-
ing for characterization of clinical isolates of methicillin-resistant Staphylococcus aureus in the Univer-
sity Clinical Center in Gdańsk, Poland. Folia Microbiol (Praha). 2012; 57: 243–249. doi: 10.1007/
s12223-012-0148-z
35. Rijnders MIA, Deurenberg RH, Boumans MLL, Hoogkamp-Korstanje JA, Beisser PS, Antibiotic Resis-
tance Surveillance Group, et al. Population structure of Staphylococcus aureus strains isolated from
intensive care unit patients in the netherlands over an 11-year period (1996 to 2006). J Clin Microbiol.
2009; 47: 4090–4095. doi: 10.1128/JCM.00820-09 PMID: 19812275
36. Schaumburg F, Köck R, Mellmann A, Richter L, Hasenberg F, Kriegeskorte A, et al. Population dynam-
ics among methicillin-resistant Staphylococcus aureus isolates in Germany during a 6-year period. J
Clin Microbiol. 2012; 50: 3186–3192. doi: 10.1128/JCM.01174-12 PMID: 22814464
37. Grundmann H, Schouls LM, Aanensen DM, Pluister GN, Tami A, Chlebowicz M, et al. The dynamic
changes of dominant clones of Staphylococcus aureus causing bloodstream infections in the European
region: results of a second structured survey. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis
Bull. 2014; 19.
38. Hudson LO, Murphy CR, Spratt BG, Enright MC, Terpstra L, Gombosev A, et al. Differences in methicil-
lin-resistant Staphylococcus aureus strains isolated from pediatric and adult patients from hospitals in a
Clonal Structure Characterization S. aureus Invasive Infections in Paediatric Patients South Poland
PLOS ONE | DOI:10.1371/journal.pone.0151937 March 18, 2016 22 / 25
large county in California. J Clin Microbiol. 2012; 50: 573–579. doi: 10.1128/JCM.05336-11 PMID:
22205805
39. Nowrouzian FL, Ali A, Badiou C, Dauwalder O, Lina G, Josefsson E. Impacts of enterotoxin gene clus-
ter-encoded superantigens on local and systemic experimental Staphylococcus aureus infections. Eur
J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol. 2015; doi: 10.1007/s10096-015-2371-4
40. Kinnevey PM, Shore AC, Brennan GI, Sullivan DJ, Ehricht R, Monecke S, et al. Extensive genetic diver-
sity identified among sporadic methicillin-resistant Staphylococcus aureus isolates recovered in Irish
hospitals between 2000 and 2012. Antimicrob Agents Chemother. 2014; 58: 1907–1917. doi: 10.1128/
AAC.02653-13 PMID: 24395241
41. Luedicke C, Slickers P, Ehricht R, Monecke S. Molecular fingerprinting of Staphylococcus aureus from
bone and joint infections. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol. 2010; 29: 457–
463. doi: 10.1007/s10096-010-0884-4
42. WehrhahnMC, Robinson JO, Pascoe EM, Coombs GW, Pearson JC, O’Brien FG, et al. Illness severity
in community-onset invasive Staphylococcus aureus infection and the presence of virulence genes. J
Infect Dis. 2012; 205: 1840–1848. doi: 10.1093/infdis/jis279 PMID: 22492857
43. Argudín MA, Mendoza MC, González-Hevia MA, Bances M, Guerra B, Rodicio MR. Genotypes, exo-
toxin gene content, and antimicrobial resistance of Staphylococcus aureus strains recovered from
foods and food handlers. Appl Environ Microbiol. 2012; 78: 2930–2935. doi: 10.1128/AEM.07487-11
PMID: 22327598
44. Chen X, WangW-K, Han L-Z, Liu Y, Zhang H, Tang J, et al. Epidemiological and genetic diversity of
Staphylococcus aureus causing bloodstream infection in Shanghai, 2009–2011. PloS One. 2013; 8:
e72811. doi: 10.1371/journal.pone.0072811 PMID: 24039803
45. Yu F, Li T, Huang X, Xie J, Xu Y, Tu J, et al. Virulence gene profiling and molecular characterization of
hospital-acquired Staphylococcus aureus isolates associated with bloodstream infection. Diagn Micro-
biol Infect Dis. 2012; 74: 363–368. doi: 10.1016/j.diagmicrobio.2012.08.015 PMID: 23021064
46. Chung J-W, Karau MJ, Greenwood-Quaintance KE, Ballard AD, Tilahun A, Khaleghi SR, et al. Super-
antigen profiling of Staphylococcus aureus infective endocarditis isolates. Diagn Microbiol Infect Dis.
2014; 79: 119–124. doi: 10.1016/j.diagmicrobio.2014.03.009 PMID: 24745820
47. vanWamel WJB, Rooijakkers SHM, Ruyken M, van Kessel KPM, van Strijp JAG. The Innate Immune
Modulators Staphylococcal Complement Inhibitor and Chemotaxis Inhibitory Protein of Staphylococ-
cus aureus Are Located on β-Hemolysin-Converting Bacteriophages. J Bacteriol. 2006; 188: 1310–
1315. doi: 10.1128/JB.188.4.1310-1315.2006 PMID: 16452413
48. Rooijakkers SHM, Ruyken M, van Roon J, van Kessel KPM, van Strijp JAG, vanWamel WJB. Early
expression of SCIN and CHIPS drives instant immune evasion by Staphylococcus aureus. Cell Micro-
biol. 2006; 8: 1282–1293. doi: 10.1111/j.1462-5822.2006.00709.x PMID: 16882032
49. Peton V, Le Loir Y. Staphylococcus aureus in veterinary medicine. Infect Genet Evol J Mol Epidemiol
Evol Genet Infect Dis. 2013; doi: 10.1016/j.meegid.2013.08.011
50. Helbin WM, Polakowska K, Miedzobrodzki J. Phage-related virulence factors of Staphylococcus
aureus. Postepy Mikrobiol. 2012; 4: 291–298.
51. Monecke S, Müller E, Dorneanu OS, Vremeră T, Ehricht R. Molecular typing of MRSA and of clinical
Staphylococcus aureus isolates from Iaşi, Romania. PloS One. 2014; 9: e97833. doi: 10.1371/journal.
pone.0097833 PMID: 24846009
52. Verkaik NJ, Lebon A, de Vogel CP, Hooijkaas H, Verbrugh HA, Jaddoe VWV, et al. Induction of anti-
bodies by Staphylococcus aureus nasal colonization in young children. Clin Microbiol Infect Off Publ
Eur Soc Clin Microbiol Infect Dis. 2010; 16: 1312–1317. doi: 10.1111/j.1469-0691.2009.03073.x
53. Cassat JE, Dunman PM, McAleese F, Murphy E, Projan SJ, Smeltzer MS. Comparative genomics of
Staphylococcus aureusmusculoskeletal isolates. J Bacteriol. 2005; 187: 576–592. doi: 10.1128/JB.
187.2.576-592.2005 PMID: 15629929
54. Ruffing U, Akulenko R, Bischoff M, Helms V, Herrmann M, von Müller L. Matched-cohort DNAmicroar-
ray diversity analysis of methicillin sensitive and methicillin resistant Staphylococcus aureus isolates
from hospital admission patients. PloS One. 2012; 7: e52487. doi: 10.1371/journal.pone.0052487
PMID: 23285062
55. Li H, Zhao C, Chen H, Zhang F, HeW, Wang X, et al. Identification of gene clusters associated with
host adaptation and antibiotic resistance in Chinese Staphylococcus aureus isolates by microarray-
based comparative genomics. PloS One. 2013; 8: e53341. doi: 10.1371/journal.pone.0053341 PMID:
23308197
56. Rasmussen G, Monecke S, Brus O, Ehricht R, Söderquist B. Long term molecular epidemiology of
methicillin-susceptible Staphylococcus aureus bacteremia isolates in Sweden. PloS One. 2014; 9:
e114276. doi: 10.1371/journal.pone.0114276 PMID: 25479442
Clonal Structure Characterization S. aureus Invasive Infections in Paediatric Patients South Poland
PLOS ONE | DOI:10.1371/journal.pone.0151937 March 18, 2016 23 / 25
57. Monecke S, Luedicke C, Slickers P, Ehricht R. Molecular epidemiology of Staphylococcus aureus in
asymptomatic carriers. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol. 2009; 28: 1159–
1165. doi: 10.1007/s10096-009-0752-2
58. Post V, Wahl P, Uçkay I, Ochsner P, Zimmerli W, Corvec S, et al. Phenotypic and genotypic characteri-
sation of Staphylococcus aureus causing musculoskeletal infections. Int J Med Microbiol IJMM. 2014;
304: 565–576. doi: 10.1016/j.ijmm.2014.03.003 PMID: 24768432
59. Lindsay JA, Ruzin A, Ross HF, Kurepina N, Novick RP. The gene for toxic shock toxin is carried by a
family of mobile pathogenicity islands in Staphylococcus aureus. Mol Microbiol. 1998; 29: 527–543.
PMID: 9720870
60. Ruzin A, Lindsay J, Novick RP. Molecular genetics of SaPI1—a mobile pathogenicity island in Staphy-
lococcus aureus. Mol Microbiol. 2001; 41: 365–377. PMID: 11489124
61. Peacock SJ, Moore CE, Justice A, Kantzanou M, Story L, Mackie K, et al. Virulent Combinations of
Adhesin and Toxin Genes in Natural Populations of Staphylococcus aureus. Infect Immun. 2002; 70:
4987–4996. doi: 10.1128/IAI.70.9.4987-4996.2002 PMID: 12183545
62. Deurenberg RH, Rijnders MIA, Sebastian S, Welling MA, Beisser PS, Stobberingh EE. The Staphylo-
coccus aureus lineage-specific markers collagen adhesin and toxic shock syndrome toxin 1 distinguish
multilocus sequence typing clonal complexes within spa clonal complexes. Diagn Microbiol Infect Dis.
2009; 65: 116–122. doi: 10.1016/j.diagmicrobio.2009.07.007 PMID: 19748421
63. Rojo A, Aguinaga A, Monecke S, Yuste JR, Gastaminza G, España A. Staphylococcus aureus genomic
pattern and atopic dermatitis: may factors other than superantigens be involved? Eur J Clin Microbiol
Infect Dis Off Publ Eur Soc Clin Microbiol. 2014; 33: 651–658. doi: 10.1007/s10096-013-2000-z
64. Netsvyetayeva I, Fraczek M, Piskorska K, Golas M, Sikora M, Mlynarczyk A, et al. Staphylococcus
aureus nasal carriage in Ukraine: antibacterial resistance and virulence factor encoding genes. BMC
Infect Dis. 2014; 14: 128. doi: 10.1186/1471-2334-14-128 PMID: 24597648
65. Powers ME, BubeckWardenburg J. Igniting the fire: Staphylococcus aureus virulence factors in the
pathogenesis of sepsis. PLoS Pathog. 2014; 10: e1003871. doi: 10.1371/journal.ppat.1003871 PMID:
24550724
66. Ghasemian A, Najar Peerayeh S, Bakhshi B, Mirzaee M. The Microbial Surface Components Recog-
nizing Adhesive Matrix Molecules (MSCRAMMs) Genes among Clinical Isolates of Staphylococcus
aureus from Hospitalized Children. Iran J Pathol. 2015; 10: 258–264. PMID: 26351495
67. Schulte B, BierbaumG, Pohl K, Goerke C, Wolz C. Diversification of clonal complex 5 methicillin-resis-
tant Staphylococcus aureus strains (Rhine-Hesse clone) within Germany. J Clin Microbiol. 2013; 51:
212–216. doi: 10.1128/JCM.01967-12 PMID: 23135939
68. Rolo J, Miragaia M, Turlej-Rogacka A, Empel J, Bouchami O, Faria NA, et al. High genetic diversity
among community-associated Staphylococcus aureus in Europe: results from a multicenter study.
PloS One. 2012; 7: e34768. doi: 10.1371/journal.pone.0034768 PMID: 22558099
69. Monecke S, Jatzwauk L, Weber S, Slickers P, Ehricht R. DNAmicroarray-based genotyping of methicil-
lin-resistant Staphylococcus aureus strains from Eastern Saxony. Clin Microbiol Infect Off Publ Eur Soc
Clin Microbiol Infect Dis. 2008; 14: 534–545. doi: 10.1111/j.1469-0691.2008.01986.x
70. Wannet WJB, Spalburg E, Heck MEOC, Pluister GN, Willems RJL, de Neeling AJ. Widespread Dis-
semination in The Netherlands of the Epidemic Berlin Methicillin-Resistant Staphylococcus aureus
Clone with Low-Level Resistance to Oxacillin. J Clin Microbiol. 2004; 42: 3077–3082. doi: 10.1128/
JCM.42.7.3077-3082.2004 PMID: 15243063
71. Witte W, Kresken M, Braulke C, Cuny C. Increasing incidence and widespread dissemination of methi-
cillin-resistant Staphylococcus aureus (MRSA) in hospitals in central Europe, with special reference to
German hospitals. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 1997; 3: 414–422.
72. Sá-Leão R, Santos Sanches I, Dias D, Peres I, Barros RM, de Lencastre H. Detection of an archaic
clone of Staphylococcus aureuswith low-level resistance to methicillin in a pediatric hospital in Portugal
and in international samples: relics of a formerly widely disseminated strain? J Clin Microbiol. 1999; 37:
1913–1920. PMID: 10325346
73. Aires de Sousa M, Conceição T, Simas C, de Lencastre H. Comparison of genetic backgrounds of
methicillin-resistant and -susceptible Staphylococcus aureus isolates from Portuguese hospitals and
the community. J Clin Microbiol. 2005; 43: 5150–5157. doi: 10.1128/JCM.43.10.5150-5157.2005
PMID: 16207977
74. Polin RA, Denson S, Brady MT, Committee on Fetus and Newborn, Committee on Infectious Diseases.
Epidemiology and diagnosis of health care-associated infections in the NICU. Pediatrics. 2012; 129:
e1104–1109. doi: 10.1542/peds.2012-0147 PMID: 22451708
75. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, et al. Invasive methicillin-resistant
Staphylococcus aureus infections in the United States. JAMA. 2007; 298: 1763–1771. doi: 10.1001/
jama.298.15.1763 PMID: 17940231
Clonal Structure Characterization S. aureus Invasive Infections in Paediatric Patients South Poland
PLOS ONE | DOI:10.1371/journal.pone.0151937 March 18, 2016 24 / 25
76. Nakao A, Ito T, Han X, Lu YJ, Hisata K, Tsujiwaki A, et al. Intestinal carriage of methicillin-resistant
Staphylococcus aureus in nasal MRSA carriers hospitalized in the neonatal intensive care unit. Antimi-
crob Resist Infect Control. 2014; 3: 14. doi: 10.1186/2047-2994-3-14 PMID: 24808943
77. Garcia C, Acuña-Villaorduña A, Dulanto A, Vandendriessche S, Hallin M, Jacobs J, et al. Dynamics of
nasal carriage of methicillin-resistant Staphylococcus aureus among healthcare workers in a tertiary-
care hospital in Peru. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol. 2016; 35: 89–93.
doi: 10.1007/s10096-015-2512-9
78. Regev-Yochay G, Rubinstein E, Barzilai A, Carmeli Y, Kuint J, Etienne J, et al. Methicillin-resistant
Staphylococcus aureus in Neonatal Intensive Care Unit. Emerg Infect Dis. 2005; 11: 453–456. doi: 10.
3201/eid1103.040470 PMID: 15757564
79. Albrich WC, Harbarth S. Health-care workers: source, vector, or victim of MRSA? Lancet Infect Dis.
2008; 8: 289–301. doi: 10.1016/S1473-3099(08)70097-5 PMID: 18471774
80. Kupferschmidt K. Infectious diseases. Genome study helps contain MRSA outbreak—and breeds new
questions. Science. 2012; 338: 1019. doi: 10.1126/science.338.6110.1019 PMID: 23180838
81. Dramowski A, Cotton MF, Rabie H, Whitelaw A. Trends in paediatric bloodstream infections at a South
African referral hospital. BMC Pediatr. 2015; 15: 33. doi: 10.1186/s12887-015-0354-3 PMID: 25884449
Clonal Structure Characterization S. aureus Invasive Infections in Paediatric Patients South Poland
PLOS ONE | DOI:10.1371/journal.pone.0151937 March 18, 2016 25 / 25
